Effegad 150 Mg 28 Capsules

Effegad 150 Mg 28 Capsules

Description:

Effegad 150 mg 28 capsules is a prescription antidepressant medicine containing venlafaxine, a serotonin and norepinephrine reuptake inhibitor (SNRI). It is used to treat major depressive disorder and certain anxiety disorders by restoring the balance of key neurotransmitters in the brain. Effegad 150 mg extended-release (e.r.) capsules are designed for once-daily dosing to provide stable blood levels throughout the day, helping to improve mood, reduce anxiety, and relieve associated physical and emotional symptoms. This product is intended for adult use under the supervision of a healthcare professional.

Indications:

• Treatment of major depressive disorder (MDD), including persistent low mood, loss of interest, fatigue, and sleep/appetite disturbances.
• Management of generalized anxiety disorder (GAD), including excessive worry, restlessness, and muscle tension.
• Treatment of social anxiety disorder (social phobia), including intense fear or anxiety in social or performance situations.
• May help reduce associated symptoms such as poor concentration, irritability, and physical symptoms related to anxiety and depression (e.g., palpitations, headaches, digestive discomfort), as assessed by a physician.

Active Ingredients / Key Components:

• Venlafaxine – 150 mg per extended-release capsule.
• Excipients: Full list of inactive ingredients (capsule shell, fillers, stabilizers, colorants) is not available in the provided information. Please refer to the package leaflet for complete excipient details.

Dosage & Administration / How to Use:

• Effegad 150 mg is an extended-release capsule intended for oral use only.
• Usual adult dose: As prescribed by the physician. Treatment often starts at a lower dose and may be gradually increased to 150 mg once daily, depending on response and tolerability.
• Take once daily at approximately the same time each day, preferably with food to reduce the risk of gastrointestinal side effects.
• Swallow the capsule whole with a glass of water. Do not crush, chew, or open the capsule, as this will affect the extended-release properties.
• Do not change the dose or stop taking Effegad suddenly without consulting your doctor, as abrupt discontinuation may cause withdrawal symptoms (e.g., dizziness, headache, irritability, sleep disturbances).
• If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not double the dose to make up for a missed dose.
• Duration of treatment is determined by your doctor; antidepressant therapy is usually continued for several months after symptoms improve to prevent relapse.

Clinical Benefits:

• Helps relieve symptoms of major depression by enhancing serotonin and norepinephrine activity in the central nervous system.
• Reduces excessive worry, tension, and restlessness associated with generalized anxiety disorder.
• Improves ability to function in social situations and reduces fear and avoidance in social anxiety disorder.
• Supports better overall daily functioning, including concentration, motivation, and sleep quality, as part of a comprehensive treatment plan.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to venlafaxine or any of the capsule components.
• Do not use Effegad in combination with monoamine oxidase inhibitors (MAOIs) or within 14 days of stopping an MAOI. Allow at least 7 days after stopping venlafaxine before starting an MAOI.
• Use with caution in patients with a history of bipolar disorder or mania; antidepressants may precipitate a manic episode in susceptible individuals.
• May increase the risk of suicidal thoughts and behavior, especially in young adults at the beginning of treatment or after dose changes; close monitoring is required.
• Use with caution in patients with cardiovascular disease, uncontrolled hypertension, or arrhythmias, as venlafaxine can increase blood pressure and heart rate.
• Use with caution in patients with kidney or liver impairment; dose adjustment may be required.
• May increase the risk of bleeding, especially when used with anticoagulants, antiplatelet agents, or NSAIDs.
• Serotonin syndrome may occur if taken with other serotonergic drugs (e.g., other antidepressants, triptans, tramadol, St. John’s wort); seek urgent medical help if symptoms such as agitation, confusion, rapid heart rate, fever, muscle stiffness, or tremor occur.
• Consult your doctor before use if pregnant or planning pregnancy. Venlafaxine should be used during pregnancy only if the potential benefit justifies the potential risk.
• Venlafaxine passes into breast milk; breastfeeding is not recommended unless clearly needed and under medical supervision.
• May cause dizziness, drowsiness, or blurred vision; avoid driving or operating machinery until you know how the medicine affects you.
• Not intended to diagnose, treat, cure, or prevent any disease without medical supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects may include nausea, vomiting, dry mouth, loss of appetite, constipation, headache, dizziness, drowsiness, insomnia, increased sweating, and nervousness.
• Other possible side effects: increased blood pressure, palpitations, sexual dysfunction (e.g., decreased libido, difficulty achieving orgasm), tremor, and blurred vision.
• Serious side effects (seek immediate medical attention): signs of serotonin syndrome (agitation, confusion, fever, rapid heartbeat, muscle stiffness), severe allergic reactions (rash, itching, swelling of face/lips/tongue, difficulty breathing), seizures, severe or persistent high blood pressure, or suicidal thoughts or behavior.
• If you experience any unusual or bothersome symptoms, contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight and moisture. Keep the blister pack or container tightly closed. Do not use after the expiry date shown on the package. Keep out of reach of children.

Specifications:

• Strength: 150 mg venlafaxine per extended-release capsule.
• Form: Capsule (extended-release).
• Pack size: 28 capsules per pack.
• Intended use: Prescription antidepressant and anxiolytic medicine for adults, under medical supervision.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.